ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

ASPIRIN AS A PROPHYLAXIS IN PRE-ECLAMPSIA AND ITS COMPLICATIONS IN MEDINA, SAUDI ARABIA

Tameem Jayousi , Afnan Eid Alharbi , Shifaa Saud Ghazi Alamri , Nuha Salah Alsuhaymi , Alaa Ibrahim Iskandar alhendi

Background: Low-dose aspirin has been used during pregnancy most commonly to prevent or delay the onset of pre-eclampsia. World Health Organization guideline recommended that low-dose aspirin (75 mg/day) be initiated before 20 weeks of gestation for women at high risk of preeclampsia Objective: to investigate the effectiveness of aspirin prescription in the prophylaxis of pre-eclampsia and its complications among Saudi women in almadinah region Method: we sought to examine the influence of compliance on the beneficial effect of aspirin in prevention of preeclampsia in the Aspirin for Evidence-Based Preeclampsia Prevention trial. A cross sectional study was carried out at Al-Madinah Al-Monawarah, Kingdom of Saudi Arabia, including medina city urban and rural area. The study was done at general population at madinah , kingdom of Saudi Arabia. Using an electronic questionnaire that was distributed to population online through different types of social media ( e mail, whatsapp and twitter) . The sample size is 700. Data was collected by a semi structured questionnaire prepared by the researchers Result: We found that it was effective in 32.1% in the reduction of severity or complication while 49.3% not effective. Conclusion: We found that the use of low-dose aspirin wasn’t effective as a prophylaxis of pre-eclampsia and its complications. We recommend doing this study all over the kingdom for more cases and more accurate results. Key words: Pre-eclampsia, Saudi Arabia, Medina, hypertension, diabetes mellitus.

FULL TEXT